Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories is expecting to launch the generic version of Copaxone in the US market during the first half of FY20. Copaxone (glatiramer acetate injection) is a multi-billion dollar drug and a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.